淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7103人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302326, encodeId=a1d813023262d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例, objectType=article, longId=197237, objectId=b6f419e237c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6f419e237c9, replyNumber=0, likeNumber=71, createdTime=2020-07-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6f419e237c9, moduleTitle=地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6f419e237c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302325, encodeId=a229130232540, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局, objectType=article, longId=196795, objectId=2109196e95bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2109196e95bc, replyNumber=0, likeNumber=67, createdTime=2020-07-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2109196e95bc, moduleTitle=Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2109196e95bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302324, encodeId=9ef11302324b6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Bcl-2联合BTK抑制剂治疗慢性淋巴细胞淋巴瘤, objectType=article, longId=196296, objectId=7b82196296b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b82196296b4, replyNumber=0, likeNumber=85, createdTime=2020-06-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b82196296b4, moduleTitle=Bcl-2联合BTK抑制剂治疗慢性淋巴细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b82196296b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302323, encodeId=3a39130232391, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, objectType=article, longId=195407, objectId=8e5719540e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5719540e54, replyNumber=0, likeNumber=87, createdTime=2020-06-07, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5719540e54, moduleTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5719540e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302322, encodeId=a88e1302322fb, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性, objectType=article, longId=195082, objectId=032019508269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=032019508269, replyNumber=0, likeNumber=57, createdTime=2020-06-02, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=032019508269, moduleTitle=J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=032019508269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302321, encodeId=7e261302321e7, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, objectType=article, longId=194212, objectId=13c2194212aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2194212aa, replyNumber=0, likeNumber=57, createdTime=2020-05-17, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2194212aa, moduleTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c2194212aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302320, encodeId=4544130232045, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , objectType=article, longId=193856, objectId=ff2119385640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff2119385640, replyNumber=0, likeNumber=0, createdTime=2020-05-11, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff2119385640, moduleTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff2119385640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302319, encodeId=1207130231900, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, objectType=article, longId=193606, objectId=c7931936061f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7931936061f, replyNumber=0, likeNumber=0, createdTime=2020-05-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7931936061f, moduleTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7931936061f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302318, encodeId=319313023185a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=IBD：中性粒细胞与淋巴细胞之比（NLR）和血小板与淋巴细胞之比（PLR）可作为抗TNF治疗溃疡性结肠炎患者黏膜愈合的新型预后生物标志物, objectType=article, longId=193452, objectId=042019345241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=042019345241, replyNumber=0, likeNumber=61, createdTime=2020-05-05, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=042019345241, moduleTitle=IBD：中性粒细胞与淋巴细胞之比（NLR）和血小板与淋巴细胞之比（PLR）可作为抗TNF治疗溃疡性结肠炎患者黏膜愈合的新型预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=042019345241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302317, encodeId=5ce0130231e6d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, objectType=article, longId=193184, objectId=fb6d193184c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6d193184c5, replyNumber=0, likeNumber=58, createdTime=2020-05-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6d193184c5, moduleTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6d193184c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302316, encodeId=6a82130231619, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌, objectType=article, longId=193170, objectId=53521931e076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53521931e076, replyNumber=0, likeNumber=61, createdTime=2020-05-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53521931e076, moduleTitle=AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53521931e076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302315, encodeId=319d1302315a7, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子, objectType=article, longId=192538, objectId=a333192538d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a333192538d4, replyNumber=0, likeNumber=64, createdTime=2020-04-21, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a333192538d4, moduleTitle=Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a333192538d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302314, encodeId=012c130231458, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著, objectType=article, longId=192479, objectId=9a741924e989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a741924e989, replyNumber=0, likeNumber=56, createdTime=2020-04-20, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a741924e989, moduleTitle=Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a741924e989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302313, encodeId=bf1113023132b, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=SCIENCE：邵峰组发现细胞毒性淋巴细胞诱导细胞焦亡的机制, objectType=article, longId=192418, objectId=09cf19241801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09cf19241801, replyNumber=0, likeNumber=90, createdTime=2020-04-19, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09cf19241801, moduleTitle=SCIENCE：邵峰组发现细胞毒性淋巴细胞诱导细胞焦亡的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09cf19241801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302312, encodeId=1251130231296, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Clinica Chimica Acta：血尿酸与淋巴细胞比值是一种新的早期肺癌手术切除预后生物标志物？, objectType=article, longId=192176, objectId=97f11921e615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97f11921e615, replyNumber=0, likeNumber=0, createdTime=2020-04-14, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97f11921e615, moduleTitle=Clinica Chimica Acta：血尿酸与淋巴细胞比值是一种新的早期肺癌手术切除预后生物标志物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97f11921e615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302311, encodeId=72231302311b4, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, objectType=article, longId=191730, objectId=1f9c191e301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9c191e301a, replyNumber=0, likeNumber=114, createdTime=2020-04-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9c191e301a, moduleTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f9c191e301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302310, encodeId=b6cc13023106a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, objectType=article, longId=191470, objectId=27641914e046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27641914e046, replyNumber=0, likeNumber=89, createdTime=2020-04-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27641914e046, moduleTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27641914e046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302309, encodeId=8b67130230998, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：既往20余年结节性淋巴细胞为主型霍奇金淋巴瘤的治疗预后, objectType=article, longId=191227, objectId=145d19122ecc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=145d19122ecc, replyNumber=0, likeNumber=70, createdTime=2020-04-03, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=145d19122ecc, moduleTitle=Blood：既往20余年结节性淋巴细胞为主型霍奇金淋巴瘤的治疗预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=145d19122ecc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302308, encodeId=72f8130230812, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生, objectType=article, longId=191221, objectId=a8c7191221b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c7191221b6, replyNumber=0, likeNumber=61, createdTime=2020-04-03, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c7191221b6, moduleTitle=Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8c7191221b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302307, encodeId=7c62130230e86, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Eur Arch Otorhinolaryngol：中性粒细胞与淋巴细胞比例在先天性突发感觉神经听力损失中的预后价值调查 , objectType=article, longId=190996, objectId=2a2e19099633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a2e19099633, replyNumber=0, likeNumber=92, createdTime=2020-03-29, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a2e19099633, moduleTitle=Eur Arch Otorhinolaryngol：中性粒细胞与淋巴细胞比例在先天性突发感觉神经听力损失中的预后价值调查 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a2e19099633)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例

2020-07-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局

2020-07-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Bcl-2联合BTK抑制剂治疗慢性淋巴细胞淋巴瘤

2020-06-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解

2020-06-07

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性

2020-06-02

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知

2020-05-17

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标

2020-05-11

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者

2020-05-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

IBD：中性粒细胞与淋巴细胞之比（NLR）和血小板与淋巴细胞之比（PLR）可作为抗TNF治疗溃疡性结肠炎患者黏膜愈合的新型预后生物标志物

2020-05-05

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布

2020-05-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌

2020-05-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子

2020-04-21

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著

2020-04-20

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

SCIENCE：邵峰组发现细胞毒性淋巴细胞诱导细胞焦亡的机制

2020-04-19

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Clinica Chimica Acta：血尿酸与淋巴细胞比值是一种新的早期肺癌手术切除预后生物标志物？

2020-04-14

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准

2020-04-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND

2020-04-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：既往20余年结节性淋巴细胞为主型霍奇金淋巴瘤的治疗预后

2020-04-03

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生

2020-04-03

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Eur Arch Otorhinolaryngol：中性粒细胞与淋巴细胞比例在先天性突发感觉神经听力损失中的预后价值调查

2020-03-29

科室
- - 订阅+
  - 更多科室
工具
服务